Free UK Delivery on orders over £49

Clindaseptin 25mg/ml Oral Solution for Cats and Dogs 22ml

Item Number: CLINDASEPT

Clindaseptin 25mg/ml Oral Solution for Cats and Dogs 22ml
  • 22ml

    In Stock

    £ 11.59

    Web code: Q10611

Total: £0.00

Choose quantity to add to basket

 

 


Browse other products from the Clindaseptin product range

Description

Clindaseptin 25 mg/ml Oral Solution for Cats and Dogs 22ml.

Presentation

Oral solution.

Clear, colourless solution.

Uses

Cats:

For the treatment of infected wounds and abscesses caused by clindamycin-sensitive species of Staphylococcus spp and Streptococcus spp.

Dogs:

For the treatment of infected wounds, abscesses and oral cavity/dental infections caused by or associated with clindamycin-sensitive species of Staphylococcus spp, Streptococcus spp, Bacteroides spp, Fusobacterium necrophorum, Clostridium perfringens

Adjunctive treatment of mechanical or surgical periodontal therapy in the treatment of infections of the gingival and periodontal tissues

For the treatment of osteomyelitis caused by Staphylococcus aureus

Dosage and administration

For oral administration only.

Recommended dosage:

Cats:

- infected wounds, abscesses: 11 mg clindamycin per kg of body weight per 24h or 5.5 mg /kg per 12h for 7 to 10 days

The treatment should be stopped if no therapeutic effect is observed after 4 days.

Dogs:

- Infected wounds, abscesses and oral cavity/dental infections: 11 mg clindamycin per kg of body weight per 24h or 5.5 mg /kg per 12h for 7 to 10 days.

The treatment should be stopped if no therapeutic effect is observed after 4 days.

- Treatment of bone infections (osteomyelitis): 11 mg clindamycin per kg of body weight every 12 hours during a period of 28 days minimum. The treatment should be discontinued if no therapeutic effect is observed in the first 14 days.

Dosage

Volume to be administered per kg bodyweight

5.5 mg/kg

Corresponding approximately to 0.25 ml per kg

11 mg/kg

Corresponding approximately to 0.5 ml per kg

A 3 ml graduated syringe is provided to facilitate the administration of the veterinary medicinal product.

Contra-indications, warnings, etc

Do not use in rabbits, hamsters, guinea pigs, chinchillas, horses or ruminants because ingestion of clindamycin by these species may cause severe gastrointestinal disorders.

Do not use in cases of hypersensitivity to either clindamycin or lincomycin, or to any of the excipients.

Special warnings

None.

Special precautions for use in animals

Inappropriate use of the product may increase the prevalence of bacteria resistant to clindamycin. Whenever possible, clindamycin should only be used based on susceptibility testing.

Official national and local antimicrobial policies should be taken into account when the product is used.

Clindamycin shows parallel-resistance with lincomycin and co-resistance with erythromycin. There is a partial cross-resistance to erythromycin and other macrolides.

In case of administration of high doses of clindamycin or during prolonged therapy of one month or greater, tests for liver and renal functions and blood counts should be performed periodically.

In dogs and cats with kidney problems and / or liver problems, accompanied by severe metabolic aberrations, the dose to be administered should be carefully determined and their condition should be monitored by performing serum tests during treatment.

Adverse reactions (frequency and seriousness)

Vomiting and diarrhoea are occasionally observed.

Clindamycin sometimes causes the overgrowth of non-sensitive organisms such as resistant clostridia and yeasts. If superinfection occurs, the treatment should be stopped and appropriate measures should be taken based on the clinical situation.

Use during pregnancy and lactation

While high dose studies in rats suggests that clindamycin is not a teratogen and does not significantly affect the breeding performance of males and females, the safety of the veterinary medicinal product in gestating bitches/queens or breeding male dogs/cats has not been established.

Use only according to the benefit/risk assessment by the responsible veterinarian.

Clindamycin can pass the blood-milk barrier. As a consequence, treatment of lactating females can cause diarrhoea in puppies.

Interaction with other medicinal products and other forms of interaction

Neuromuscular blocking effects were observed with clindamycin, which may possibly enhance the activity of other neuromuscular blocking agents. The simultaneous use of such products must be made with caution.

Do not use clindamycin together with chloramphenicol or macrolides as they share the same binding site on the ribosomes.

During the simultaneous use of clindamycin and aminoglycosides (e.g. gentamicin), the risk of adverse interactions (acute renal failure) cannot be excluded.

Clindamycin may reduce the levels of cyclosporine, concomitant use should be avoided.

User warnings

Wash hands after administration.

People with known hypersensitivity to lincosamides (lincomycin and clindamycin) should avoid contact with the veterinary medicinal product.

In case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label to the physician.

Overdose

Doses of 300 mg / kg were tolerated by dogs without having adverse effects. Vomiting, loss of appetite, diarrhoea, leukocytosis and elevations in liver enzymes (AST, ALT) were observed occasionally. In such cases, discontinue treatment immediately and establish a symptomatic treatment.

Withdrawal periods

Not applicable

Incompatibilities

Do not mix this product with any other veterinary medicinal products

Pharmaceutical precautions

This veterinary medicinal product does not require any special storage conditions.

Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.

Legal category

POM-V

Packaging Quantities

Carton box containing clear polyethylene terephthalate (PET) bottle or Type III amber glass bottle of 22 ml with HDPE/LDPE or polypropylene tamper proof closure supplied with a low density polyethylene measuring syringe.

Frequently Asked Questions

Ask Question

Ask a question about Clindaseptin 25mg/ml Oral Solution for Cats and Dogs 22ml